Pharmaceutical Company Reveals Cost of FDA-Approved Cannabis Based Medicine

U.K. company GW Pharmaceuticals has revealed how much their new epilepsy drug Epidiolex will cost. Epidiolex was approved for use in the U.S. by the Food and Drug Administration in June. The drug is the first medication derived from cannabis to receive approval from the agency. Continue reading “Pharmaceutical Company Reveals Cost of FDA-Approved Cannabis Based Medicine”

Georgia Parents Regain Custody of Son After Treating His Epilepsy with Cannabis

A fifteen-year-old taken into custody by Georgia’s Division of Family and Children’s Services after his parents gave him marijuana to stop his severe seizures has been reunited with his family after more than a month of separation.

On Monday, the Twiggs County Juvenile Court issued a protective order outlining the conditions under which Matthew and Suzeanna Brill could regain custody of their son, David Ray. The Brills still face criminal charges for providing their son with cannabis. But following the conditions of the protective order could lead to the case’s dismissal. Continue reading “Georgia Parents Regain Custody of Son After Treating His Epilepsy with Cannabis”

GW Pharmaceuticals’ FDA Win Reinforces BofA’s Bullish Thesis

The U.S. Food and Drug Administration approval of GW Pharmaceuticals PLC (NASDAQ: GWPH)’s epidiolex therapy for the treatment of seizures was expected — and reinforces the bullish case for owning the stock, according to Bank of America Merrill Lynch. Continue reading “GW Pharmaceuticals’ FDA Win Reinforces BofA’s Bullish Thesis”

What Zynerba’s Flop Means For CBD Therapies And GW Pharmaceuticals

Shares of Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) lost more than 58 percent of their value Monday morning after the company reported disappointing results from its phase 2 STAR 1 clinical trial Continue reading “What Zynerba’s Flop Means For CBD Therapies And GW Pharmaceuticals”

Study Proves Marijuana Can Reduce Epileptic Seizures

Medical researchers have confirmed what some desperate parents have been claiming for years—that a nonpsychoactive component of marijuana known as cannabidiol (CBD) can reduce epileptic seizures in some children.

Published in The New England Journal of Medicine, the findings stem from a double-blind, placebo-controlled study—the most scientifically rigorous type of investigation possible. Continue reading “Study Proves Marijuana Can Reduce Epileptic Seizures”